tiprankstipranks

BioLife Solutions price target raised to $30 from $27 at H.C. Wainwright

BioLife Solutions price target raised to $30 from $27 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on BioLife Solutions (BLFS) to $30 from $27 and keeps a Buy rating on the shares following the Q4 beat. The firm says the company’s cell processing platform has delivered five consecutive quarters of revenue growth. The firm cites BioLife’s “strong financial performance” for the higher target.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue